Fusion Antibodies plc (AIM:FAB)

Fusion Antibodies Revenue

Fusion Antibodies had revenue of 1.21M GBP in the half year ending September 30, 2024, a decrease of -35.21%. This brings the company's revenue in the last twelve months to 1.80M, up 14.12% year-over-year. In the fiscal year ending March 31, 2024, Fusion Antibodies had annual revenue of 1.14M, down -60.84%.

• Revenue (ttm): 1.80M
• Revenue Growth: +14.12%
• P/S Ratio: 2.89
• Revenue / Employee: 66.74K
• Employees: 27
• Market Cap: 6.24M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	1.14M	-1.77M	-60.84%
Mar 31, 2023	2.90M	-1.90M	-39.55%
Mar 31, 2022	4.80M	634.00K	15.22%
Mar 31, 2021	4.17M	270.00K	6.93%
Mar 31, 2020	3.90M	1.71M	78.51%